{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:09:47Z","timestamp":1791468587153,"version":"4.3.4"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Many international guidelines recommend routine treatment for individuals reporting sexual contact with sexual partners with chlamydia. In October 2019, the Melbourne Sexual Health Centre (MSHC) changed routine treatment of all chlamydia contacts to selective treatment, reserving same-day treatment for those testing positive, unless patients presented with symptoms or with specific reasons.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a before-and-after study among chlamydia contacts at MSHC by comparing 12 months before the \u201croutine treatment\u201d period (December 2018 to October 2019) and after the \u201cselective treatment\u201d period (November 2019 to December 2020).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 2843 chlamydia contacts included in the analysis, chlamydia positivity was 31.9% (907\/2843). The proportion of contacts who received treatment before test results decreased from 91.1% (1380\/1515) to 55.6% (739\/1328) (P &amp;lt; .0001). We reviewed 232 of the 739 chlamydia contacts in the selective period to determine reasons for treatment; 41.4% (96\/232) were treated due to the presence of symptoms. The proportion of those who received treatment and later tested positive did not change between the 2 periods (3% [482\/1380] vs 34.2% [253\/739]; P = .750). The proportion of contacts who received unnecessary treatment (treated but tested negative) did not change between the 2 periods (65.1% [898\/1380] vs 65.8% [486\/739]; P = .750). Of the 60 who did not receive treatment but tested positive subsequently, 7 (11.7%) did not return for treatment, and it did not differ between the 2 periods (P = .370).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The selective treatment approach has reduced antibiotic consumption and likely decreased the overall workload of clinic staff by minimizing the need to treat all contacts.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiaf107","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T23:17:55Z","timestamp":1740525475000},"page":"e35-e42","source":"Crossref","is-referenced-by-count":2,"title":["Routine Treatment Versus Selective Treatment for Individuals Reporting Contact With Sexual Partners With Chlamydia: A Before-and-After Study"],"prefix":"10.1093","volume":"232","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9568-211X","authenticated-orcid":false,"given":"Danushi","family":"Wijekoon","sequence":"first","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8924-2043","authenticated-orcid":false,"given":"Marcus Y","family":"Chen","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health , Melbourne, Victoria ,","place":["Australia"]},{"name":"School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Hughes","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health , Melbourne, Victoria ,","place":["Australia"]},{"name":"School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9081-1664","authenticated-orcid":false,"given":"Christopher K","family":"Fairley","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health , Melbourne, Victoria ,","place":["Australia"]},{"name":"School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6643-5678","authenticated-orcid":false,"given":"Catriona S","family":"Bradshaw","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health , Melbourne, Victoria ,","place":["Australia"]},{"name":"School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne, Victoria ,","place":["Australia"]},{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5784-7403","authenticated-orcid":false,"given":"Jason J","family":"Ong","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health , Melbourne, Victoria ,","place":["Australia"]},{"name":"School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivette","family":"Aguirre","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1766-0657","authenticated-orcid":false,"given":"Eric P F","family":"Chow","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health , Melbourne, Victoria ,","place":["Australia"]},{"name":"School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne, Victoria ,","place":["Australia"]},{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"2025073007424101900_jiaf107-B1","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1016\/S2352-3018(19)30043-8","article-title":"Epidemiology and prevention of sexually transmitted infections in men who have sex with men at risk of HIV","volume":"6","author":"Chow","year":"2019","journal-title":"Lancet HIV"},{"key":"2025073007424101900_jiaf107-B2","article-title":"Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030","author":"World Health Organization","year":"2022"},{"key":"2025073007424101900_jiaf107-B3","volume-title":"Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: accountability for the global health sector strategies 2016\u20132021: actions for impact","author":"World Health Organization (WHO)","year":"2021"},{"key":"2025073007424101900_jiaf107-B4","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/S1473-3099(17)30310-9","article-title":"Sexually transmitted infections: challenges ahead","volume":"17","author":"Unemo","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2025073007424101900_jiaf107-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"2025073007424101900_jiaf107-B6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/0956462415615443","article-title":"2015 UK national guideline for the management of infection with Chlamydia trachomatis","volume":"27","author":"Nwokolo","year":"2016","journal-title":"Int J STD AIDS"},{"key":"2025073007424101900_jiaf107-B7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/0956462412472804","article-title":"2012 BASHH statement on partner notification for sexually transmissible infections","volume":"24","author":"McClean","year":"2013","journal-title":"Int J STD AIDS"},{"key":"2025073007424101900_jiaf107-B8","volume-title":"Guidelines for the management of symptomatic sexually transmitted infections","author":"World Health Organization (WHO)","year":"2021"},{"key":"2025073007424101900_jiaf107-B9","article-title":"Sexually transmitted infections management guidelines 2019","author":"National STD\/AIDS Control Programme, Sri Lanka College of Sexual Health and HIV Medicine","year":"2019"},{"key":"2025073007424101900_jiaf107-B10","author":"Australasian Society for HIV, Viral Hepatitis, and Sexual Health Medicine","year":"2024"},{"key":"2025073007424101900_jiaf107-B11","doi-asserted-by":"crossref","first-page":"1284665","DOI":"10.3389\/fphar.2024.1284665","article-title":"Global trends of antimicrobial resistance rates in Neisseria gonorrhoeae: a systematic review and meta-analysis","volume":"15","author":"Hooshiar","year":"2024","journal-title":"Front Pharmacol"},{"key":"2025073007424101900_jiaf107-B12","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S1473-3099(20)30154-7","article-title":"Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis","volume":"20","author":"Machalek","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2025073007424101900_jiaf107-B13","doi-asserted-by":"crossref","first-page":"e1121","DOI":"10.1093\/infdis\/jiae313","article-title":"Prevalence of cefixime-resistant Neisseria gonorrhoeae in Melbourne, Australia, 2021\u20132022","volume":"230","author":"Chow","year":"2024","journal-title":"J Infect Dis"},{"key":"2025073007424101900_jiaf107-B14","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1111\/j.1749-6632.2011.06215.x","article-title":"Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future","volume":"1230","author":"Unemo","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"2025073007424101900_jiaf107-B15","doi-asserted-by":"crossref","first-page":"e01221-19","DOI":"10.1128\/AAC.01221-19","article-title":"Trends and risk factors for antimicrobial-resistant Neisseria gonorrhoeae, Melbourne, Australia, 2007 to 2018","volume":"63","author":"Williamson","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2025073007424101900_jiaf107-B16","doi-asserted-by":"crossref","first-page":"e1121","DOI":"10.1093\/infdis\/jiae313","article-title":"Prevalence of Cefixime-Resistant Neisseria gonorrhoeae in Melbourne, Australia, 2021\u20132022","volume":"230","author":"Chow","year":"2024","journal-title":"J Infect Dis"},{"key":"2025073007424101900_jiaf107-B17","doi-asserted-by":"crossref","first-page":"e0081921","DOI":"10.1128\/JCM.00819-21","article-title":"Azithromycin and doxycycline resistance profiles of U.S. Mycoplasma genitalium strains and their association with treatment outcomes","volume":"59","author":"Wood","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2025073007424101900_jiaf107-B18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/sextrans-2019-054129","article-title":"Antimicrobial resistance in Mycoplasma genitalium sampled from the British general population","volume":"96","author":"Pitt","year":"2020","journal-title":"Sex Transm Infect"},{"key":"2025073007424101900_jiaf107-B19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fcimb.2016.00098","article-title":"Macrolide resistance in Streptococcus pneumoniae","volume":"6","author":"Schroeder","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"key":"2025073007424101900_jiaf107-B20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","journal-title":"Lancet"},{"key":"2025073007424101900_jiaf107-B21","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/sextrans-2015-052068","article-title":"Chlamydia infection in individuals reporting contact with sexual partners with chlamydia: a cross-sectional study of sexual health clinic attendees","volume":"91","author":"Huffam","year":"2015","journal-title":"Sex Transm Infect"},{"key":"2025073007424101900_jiaf107-B22","article-title":"Chlamydia treatment guidelines","author":"Melbourne Sexual Health Centre","year":"2022"},{"key":"2025073007424101900_jiaf107-B23","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1056\/NEJMoa2031631","article-title":"Azithromycin or doxycycline for asymptomatic rectal Chlamydia trachomatis","volume":"384","author":"Lau","year":"2021","journal-title":"N Engl J Med"},{"key":"2025073007424101900_jiaf107-B24","first-page":"101005","article-title":"Near-to-patient-testing to inform targeted antibiotic use for sexually transmitted infections in a public sexual health clinic: the NEPTUNE cohort study","volume":"44","author":"Vodstrcil","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"2025073007424101900_jiaf107-B25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/sextrans-2021-055382","article-title":"Non-empirical management of asymptomatic chlamydia and gonorrhoea reduces unnecessary antibiotic use fivefold: a before and after study","volume":"99","author":"Rasul","year":"2023","journal-title":"Sex Transm Infect"},{"key":"2025073007424101900_jiaf107-B26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/0956462419879615","article-title":"Are empirical antibiotics for sexual contacts of Chlamydia trachomatis still necessary?","volume":"31","author":"Parnell","year":"2020","journal-title":"Int J STD AIDS"},{"key":"2025073007424101900_jiaf107-B27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/0956462418799181","article-title":"Empiric antimicrobial treatment for asymptomatic sexual contacts of sexually transmitted infection in the era of antimicrobial resistance: time to rethink?","volume":"30","author":"Pearce","year":"2019","journal-title":"Int J STD AIDS"},{"key":"2025073007424101900_jiaf107-B28","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1186\/s12889-015-1971-3","article-title":"High prevalence of rectal gonorrhoea among men reporting contact with men with gonorrhoea: implications for epidemiological treatment","volume":"15","author":"Dutt","year":"2015","journal-title":"BMC Public Health"},{"key":"2025073007424101900_jiaf107-B29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.37201\/req\/141.2021","article-title":"Implementation of the delayed antibiotic prescribing strategy. Prospective observation study in primary care","volume":"35","author":"Llor","year":"2022","journal-title":"Rev Esp Quimioter"},{"key":"2025073007424101900_jiaf107-B30","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1017\/S0950268823000948","article-title":"Coinfection and repeat bacterial sexually transmitted infections (STI)\u2014retrospective study on male attendees of public STI clinics in an Asia Pacific city","volume":"151","author":"Chung","year":"2023","journal-title":"Epidemiol Infect"},{"key":"2025073007424101900_jiaf107-B31","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/1753-6405.13158","article-title":"Sexual health service adaptations to the coronavirus disease 2019 (COVID-19) pandemic in Australia: a nationwide online survey","volume":"45","author":"Phillips","year":"2021","journal-title":"Aust N Z J Public Health"},{"key":"2025073007424101900_jiaf107-B32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/sextrans-2020-054688","article-title":"Love during lockdown: findings from an online survey examining the impact of COVID-19 on the sexual health of people living in Australia","volume":"97","author":"Coombe","year":"2021","journal-title":"Sex Transm Infect"},{"key":"2025073007424101900_jiaf107-B33","doi-asserted-by":"crossref","first-page":"ofaa536","DOI":"10.1093\/ofid\/ofaa536","article-title":"Sexually transmitted infection diagnoses and access to a sexual health service before and after the national lockdown for COVID-19 in Melbourne, Australia","volume":"8","author":"Chow","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2025073007424101900_jiaf107-B34","doi-asserted-by":"crossref","first-page":"e1553","DOI":"10.1016\/S2214-109X(21)00442-3","article-title":"Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys","volume":"9","author":"Yadav","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2025073007424101900_jiaf107-B35","doi-asserted-by":"crossref","first-page":"e1553","DOI":"10.1016\/S2214-109X(21)00442-3","article-title":"Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys","volume":"9","author":"Yadav","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2025073007424101900_jiaf107-B36","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/14787210.2019.1640602","article-title":"Challenges and opportunities for antimicrobial stewardship in resource-rich and resource-limited countries","volume":"17","author":"Hijazi","year":"2019","journal-title":"Expert Rev Anti Infect Ther"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaf107\/62199299\/jiaf107.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/1\/e35\/62199299\/jiaf107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/1\/e35\/62199299\/jiaf107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:42:51Z","timestamp":1753875771000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/232\/1\/e35\/8045440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,27]]},"published-print":{"date-parts":[[2025,7,30]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaf107","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7,15]]},"published":{"date-parts":[[2025,2,27]]}}}